Pro-life advocates slam FDA's approval of generic abortion pill as 'unconscionable'

A pro-life group has criticised the FDA's recent approval of a generic abortion drug. Susan B. Anthony Pro-Life America called the decision 'unconscionable' and raised concerns over safety and legal implications. The organisation claims abortion drugs are now the leading cause of death nationwide.

The FDA approved a generic version of mifepristone, a drug used in medication abortions. According to Susan B. Anthony Pro-Life America, the original approval came under President Bill Clinton after pregnancy was classified as an illness. The group argues this fast-tracked process set a dangerous precedent.

The organisation also states that over 60% of abortions in the US now involve abortion drugs. They highlight reported complications such as haemorrhage, infections, and the need for emergency surgery. However, no specific data on emergency room treatments in 2022 was available in search results.

Generic drugs typically do not require separate safety and effectiveness studies, a point the pro-life group finds troubling. They also claim the abortion pill undermines state-level abortion restrictions. Meanwhile, the Department of Health and Human Services (HHS) is reviewing adverse effect reports to assess the FDA's risk management programme.

HHS Communications Director Andrew Nixon noted that the FDA has limited flexibility in approving generic drugs. The agency must follow existing regulations, which do not always allow for additional scrutiny.

The debate over mifepristone continues as pro-life advocates push for stricter oversight. HHS is examining complication reports to determine if current safeguards are adequate. The FDA's approval process for generic versions remains under scrutiny by both supporters and opponents of abortion rights.